scholarly journals Correlations between Antioxidant and Biochemical Parameters of Blood Serum of Duroc Breed Pigs

Animals ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 2400
Author(s):  
Sergei Yu. Zaitsev ◽  
Anna A. Belous ◽  
Oksana A. Voronina ◽  
Roman A. Rykov ◽  
Nadezhda V. Bogolyubova
Keyword(s):  
Calcium Ions ◽  
Biochemical Parameters ◽  
Animal Health ◽  
Health Production ◽  
Moderate Correlation ◽  
Biochemical Status ◽  
Group 3 ◽  
Group 2 ◽  
Very High ◽  
Group 1

Correlations between the major biochemical (BC) and antioxidant (TAWSA) parameters of pigs’ blood are necessary to study in order to assess physiological–biochemical status (PhBS), animal health, production, etc. Blood samples were obtained from Duroc breed boars (n = 77), divided into groups 1 (n = 25), 2 (n = 40) and 3 (n = 12), which were fattened for 65, 72 and 100 days, respectively. Significant positive and negative correlations were found between TAWSA and BC parameters of pigs’ blood for group 3: very high in the case of total protein (TP) (−0.75) and aspartate aminotransferase (AST) (−0.79); high in the case of cholesterol (−0.72), glucose (0.66), alkaline phosphatase (0.66), calcium ions (−0.60) and globulins (0.53); moderate in the case of albumins (−0.36), triglycerides (−0.35), magnesium (−0.32) and phosphorus (−0.27). The same was found for group 2: high in the case of TP (0.51); moderate in the case of globulins (0.48), cholesterol (0.33) and phosphates (0.25). The only moderate correlation was found for group 1: magnesium (−0.48), glucose (0.36) and calcium (−0.25). This tendency indicated the stabilization of pig PhBS during growth and fattening, which can be useful for understanding the PhBS and antioxidant features of pigs, the factors of their nutrition, maintenance, etc.

High-dose lidocaine does not affect defibrillation efficacy: implications for defibrillation mechanisms

1998 ◽  
Vol 274 (4) ◽  
pp. H1113-H1120 ◽  
Author(s):  
Michael R. Ujhelyi ◽  
J. Jason Sims ◽  
Allison Winecoff Miller
Keyword(s):  
Ventricular Fibrillation ◽  
Cycle Length ◽  
Low Dose ◽  
High Dose ◽  
Channel Blockade ◽  
Group 3 ◽  
Baseline Values ◽  
Group 2 ◽  
Very High ◽  
Group 1

This study assessed the effect of low (10 mg ⋅ kg−1 ⋅ h−1) and very high (18 mg ⋅ kg−1 ⋅ h−1) doses of lidocaine on defibrillation energy requirements (DER) to relate changes in indexes of sodium-channel blockade with changes in DER values using a dose-response study design. In group 1 (control; n = 6 pigs), DER values were determined at baseline and during treatment with 5% dextrose in water (D5W) and with D5W added to D5W. In group 2 ( n = 7), DER values were determined at baseline and during treatment with low-dose lidocaine followed by high-dose lidocaine. In group 3 ( n = 3), DER values were determined at baseline and high-dose lidocaine. Group 3 controlled for the order of lidocaine treatment with the addition of high-dose lidocaine after baseline. DER values in group 1 did not change during D5W. In group 2, low-dose lidocaine increased DER values by 51% ( P = 0.01), whereas high-dose lidocaine added to low-dose lidocaine reduced DER values back to within 6% of baseline values ( P = 0.02, low dose vs. high dose). DER values during high-dose lidocaine in group 3 also remained near baseline values (16.2 ± 2.7 to 12.9 ± 2.7 J), demonstrating that treatment order had no impact on group 2. Progressive sodium-channel blockade was evident as incremental reduction in ventricular conduction velocity as the lidocaine dose increased. Lidocaine also significantly increased ventricular fibrillation cycle length as the lidocaine dose increased. However, the greatest increase in DER occurred when ventricular fibrillation cycle length was minimally affected, demonstrating a negative correlation ( P = 0.04). In summary, lidocaine has an inverted U-shaped DER dose-response curve. At very high lidocaine doses, DER values are similar to baseline and tend to decrease rather than increase. Increased refractoriness during ventricular fibrillation may be the electrophysiological mechanism by which high-dose lidocaine limits the adverse effects that low-dose lidocaine has on DER values. However, there is a possibility that an unidentified action of lidocaine is responsible for these effects.

207 EFFECT OF REPEAT HORMONE STIMULATION ON THE YIELD AND IN VITRO DEVELOPMENT OF JUVENILE CALF OOCYTES

2014 ◽  
Vol 26 (1) ◽  
pp. 217
Author(s):  
X. Q. Lv ◽  
J. H. Xue ◽  
Y. L. Zhu ◽  
H. B. Liang ◽  
B. H. Xuan
Keyword(s):  
Animal Health ◽  
Ovarian Response ◽  
Oocyte Recovery ◽  
Maturation Medium ◽  
Group 3 ◽  
Group 2 ◽  
Free Environment ◽  
Calf Oocytes ◽  
Group 1

Juvenile in vitro embryo transfer can markedly reduce animal generation intervals. The purpose of this study was to investigate the ovarian response of juvenile calves and in vitro oocyte developmental capacity after superstimulation. Experiments on calves were performed in accordance with the Animal Welfare Regulations. A total of 36 donor juvenile calves on standard nutrition and in a disease-free environment, were selected from the breeding farm of the Beijing Dairy Cattle Center. At 60 days of age, calves were randomly assigned into three groups of four calves each, replicated three times. On day 1, Group 1 received a progesterone vaginal insert (CIDR, 300 mg per device); Group 2 received a CIDR and 0.5 mg oestrogen benzoate (China); Group 3 received a CIDR, 0.5 mg oestrogen benzoate, and 50 mg progesterone (China). Then, calves were injected with FSH (Folltropin-V, Bioniche Animal Health, Belleville, ON, Canada) twice daily on days 5 (40 mg/40 mg) and 6 (30 mg/30 mg) at 12 h intervals. Cumulus–oocyte complexes (COCs) were recovered from the superstimulated calves 12 to 14 h after the final FSH treatment. COCs were considered usable unless they were damaged or had expanded cumulus layers. Usable COCs were matured in vitro for 24 h in maturation medium consisting of TCM199, 10% FBS, 10 μg mL–1 FSH, 1 μg mL–1 LH, 1 μg mL–1 E2–17β, 100 IU mL–1 penicillin, 100 μg mL–1 streptomycin, with (+Cys) or without (–Cys) 100 μM Cysteamine. Each calf oocyte was cultured in one well. The final concentration added to each fertilization drop was 5 × 106 sperm mL–1. Sperm and oocytes were co-cultured in IVF-100 medium (BO liquid+10 μg mL–1 heparin, Japan) at 38.5°C, 5% CO2 and a saturated humidity for 6 to 8 h. Blastocyst production rates were determined after 7 and 8 d of in vitro culture in CR1aa medium without the addition of cysteamine. Differences among treatments in each experiment were determined by one-way ANOVA and a multiple range test. Superstimulatory results indicated that more follicles were aspirated (63.2 per calf) and more usable oocytes were recovered (48.0 per calf) in Group 1 than in the other two groups (Group 2–45.2 and 31.8, respectively; Group 3–35.4 and 28.3, respectively; P < 0.05). No difference was observed between Groups 2 and 3. Superstimulation of calves twice at 30 day intervals in Group 2 (n = 12) did not affect the number of follicles or usable oocytes (overall, 44.2 and 28.0 per calf). Maturation rates (86.5% v. 85.0%, respectively) and cleavage rates (84.4% v. 80.0%, respectively) did not differ whether cysteamine was not (–Cys; n = 318) or was (+Cys; n = 330) added to the maturation medium. However, the blastocyst rate differed significantly (12.9% v. 35.2%, respectively; P < 0.01). This study established a protocol for the superstimulation of juvenile calves with an average of 48 oocytes obtained per calf. Superstimulation and surgical oocyte recovery twice at an interval of 30 days had no adverse effect on follicle development or oocyte recovery. The novelty of this research is that the blastocyst production rate of calf oocytes (35.2%) in maturation medium supplemented with cysteamine was similar to that reported in the cow.

404 SUPEROVULATORY RESPONSE IN BEEF DONORS TREATED DURING THE FIRST FOLLICULAR WAVE OR FOUR DAYS AFTER PROGESTERONE AND ESTRADIOL ADMINISTRATION

2010 ◽  
Vol 22 (1) ◽  
pp. 358 ◽  
Author(s):  
D. Carballo Guerrero ◽  
A. Tríbulo ◽  
R. Tríbulo ◽  
H. Tríbulo ◽  
G. A. Bó
Keyword(s):  
Estrous Cycle ◽  
Animal Health ◽  
Estradiol Benzoate ◽  
Control Group ◽  
Wave Groups ◽  
Follicular Wave ◽  
Estrus Detection ◽  
Group 3 ◽  
Group 2 ◽  
Group 1

Although we have previously shown that ovarian superstimulation during the first follicular wave resulted in a successful response (Carballo Guerrero D et al. 2009 Reprod. Fertil. 21, 242), the current protocol needs to be optimized in order to be used in the field. Therefore, an experiment was designed to simplify this treatment and to compare it with the traditional superstimulation protocol using progesterone and estradiol. Simmental cows (n = 14) were subjected to 3 superstimulation treatments (2 first wave groups and 1 control group) in a crossover design (i.e. all cows received the 3 treatments and all treatments were represented on each collection day). Cows in Group 1 received a progesterone-releasing device (Cue-Mate®, Bioniche Animal Health, Belleville, Ontario, Canada) along with 0.150 mg of D + cloprostenol (PGF; Bioprost-D®, Biotay, Buenos Aires, Argentina) at random stages of the estrous cycle. A second PGF was injected 5 days after Cue-Mate® insertion, followed by GnRH (0.050 mg of lecirelin; Biosin-OV®, Biotay) 36 h later (i.e. 7 days after Cue-Mate® insertion). Based on previous studies, ovulation was expected to occur 30 to 36 h later. Therefore, superstimulation treatments were initiated 36 h after GnRH (Day 0), with a total dose of 400 mg NIH-FSH-P1 of Folltropin®-V (Bioniche Animal Health) in twice-daily decreasing doses over 4 days. Prostaglandin was administered with the last 2 Folltropin®-V injections and Cue-Mate® devices were removed with the last Folltropin®-V injection. Cows received 12.5 mg of porcine LH (Lutropin®-V, Bioniche Animal Health) 24 h after Cue-Mate® removal and were AI 12 and 24 h later. Ova/embryos were collected 7 days after porcine LH and evaluated following IETS recommendations. Cows in Group 2 were treated similarly to those in the Group 1, except they did not receive the second PGF injection 5 days after Cue-Mate® insertion (thus eliminating the need to handle animals on that day). Finally, cows in Group 3 [estradiol benzoate (EB)+P4 control group] received a Cue-Mate® plus 2.5 mg of EB (Bioestradiol®, Biotay) and 50 mg of progesterone (P4; Lab., Rio de Janeiro, Argentina) at random stages of their estrous cycle. Superstimulation treatments were initiated 4 days later (Day 0) following the same protocol used in Group 1. Data were transformed to square root and analyzed by ANOVA. Mean (± SEM) numbers of ova/embryos collected, fertilized ova, and transferable embryos did not differ among groups (12.9 ± 2.0, 9.8 ± 1.7, and 6.6 ± 1.2; 11.5 ± 1.7, 9.3 ± 1.5, and 7.7 ± 1.6; and 14.5 ± 2.8, 9.4 ± 2.3, and 6.8 ± 1.7 for Groups 1, 2, and 3, respectively). In conclusion, data demonstrated that superstimulation during the first follicular wave can be successfully used in groups of randomly cycling donors without the need for estrus detection or estradiol to synchronize follicular wave emergence. The protocol is easy to follow and embryo production is comparable to that of the estradiol and progesterone protocol.

scholarly journals Effects of particulate matter under behavioral, hematological and biochemical parameters in Wistar rats

2020 ◽  
pp. 95-104
Author(s):  
Samanta Cristina-Siebel-de-Moraes ◽  
Victória Branca Moron ◽  
Aline Belem-Machado ◽  
Paula Schmitt ◽  
Daniela Montanari-Migliavacca-Osorio ◽  
...  
Keyword(s):  
Particulate Matter ◽  
Cognitive Processes ◽  
Biochemical Parameters ◽  
Biochemical Alterations ◽  
Group 3 ◽  
Anxiety Behavior ◽  
Group 2 ◽  
Hematological And Biochemical Parameters ◽  
Locomotion Activity ◽  
Group 1

El Material Particulado (MP) puede alterar los procesos cognitivos, el comportamiento depresivo y hematológico en el modelo animal. El objetivo fue evaluar los efectos causados por MP en los parámetros conductuales, hematológicos y bioquímicos en un modelo animal. Se observaron alteraciones en la actividad locomotora de las ratas, donde hubo una disminución significativa en la locomoción del Grupo 3 (MP10) en comparación con los Grupo 1 (Control) y Grupo 2 (MP2,5). Con respecto al comportamiento de ansiedad, el Grupo 3 pasó significativamente más tiempo en brazos abiertos en comparación con el control y MP2,5. No se observaron cambios hematológicos y bioquímicos. En este estudio, se concluye que, la exposición a la MP puede causar daño neurológico y, en consecuencia, afectar a otros sistemas. Particulate matter (PM) can alter the cognitive processes, the depressive behavior, and the hematological profile in animals. This study aimed to evaluate the effects on behavioral, hematological, and biochemical parameters caused by PM in an animal model. A significant decrease in the locomotion activity of Group 3 (PM10) in relation to Group 1 (Control) and Group 2 (PM2.5) was observed. Regarding the anxiety behavior, Group 3 remained significantly the most part of the time in the open arms when compared to the control and PM2.5 groups. No hematological or biochemical alterations were observed among groups. In this study, we concluded that the exposure to particulate matter can cause neurological damages, and consequently, affect other systems.

29 to 24 Year-Clinical Results of Total Hip Arthroplasty Cemented with HA by Interface Bioactive Bone Cement (IBBC)

2011 ◽  
Vol 493-494 ◽  
pp. 366-369
Author(s):  
Hironobu Oonishi ◽  
Hiroyuki Oonishi Jr. ◽  
Shigekazu Mizokawa ◽  
Hirotsugu Ohashi ◽  
Masaru Ueno ◽  
...  
Keyword(s):  
Bone Cement ◽  
Radiolucent Line ◽  
Clinical Results ◽  
Bone Surface ◽  
Appearance Rate ◽  
Group 3 ◽  
Group 2 ◽  
The One ◽  
Very High ◽  
Group 1

To improve the fixation of bone and bone cement in THA we used Interface Bioactive Bone Cement technique (IBBC) since 1982. For prostheses 28 mm-alumina head with polyethylene socket (Kyocera Co.) were used. In IBBC not-resorbable pure crystalline HA granules (0.3– 0.5 mm) were smeared on the bone surface in one to three layers just before packing bone cement. Group 1: IBBC was used in six joints in 1982. Group 2: In 25 patients, conventional bone cement technique (non-IBBC) in the one hip (in 1985 to 1986) and IBBC technique in the other hip (in 1986) were performed in the same patients. Group 3: In 65 patients (71 joints) IBBC were performed. Neither radiolucent line nor osteolysis appeared in all case in group 1. In group 2 in Non-IBBC the appearance rate of radiolucent line and osteolysis were rather high, however in IBBC they were extremely low. In Non-IBBC loosening were seen in 5 joints in the acetabulum and in 2 joints in the femur. However, in IBBC there was no loosening. In group 3 the radiolucent line and the osteolysis appeared extremely low. There was no loosening. In Non-IBBC the appearance rate of radiolucent line and the osteolysis was very high and the rate of loosening was 20%. However, in IBBC, radiolucent line and osteolysis will be prevented eternally.

192 THE USE OF FIXED-TIME TECHNIQUES AND eCG TO SYNCHRONIZE RECIPIENTS for FROZEN - THAWED BOVINE IVF EMBRYOS

2006 ◽  
Vol 18 (2) ◽  
pp. 204 ◽  
Author(s):  
R. Remillard ◽  
M. Martínez ◽  
G. Bó ◽  
R. Mapletoft
Keyword(s):  
Embryo Transfer ◽  
Animal Health ◽  
Fixed Time ◽  
Pregnancy Rates ◽  
Group 4 ◽  
Estrus Detection ◽  
Group 3 ◽  
Group 5 ◽  
Group 2 ◽  
Group 1

Two experiments were designed to investigate the use of eCG in a fixed-time embryo transfer (FTET) protocol for Chinese Yellow crossbred recipients receiving in vitro-produced (IVP) bovine embryos. In Experiment 1, cows were observed for spontaneous estrus (Group 1) or following 500 �g cloprostenol (PGF; Schering-Plough Animal Health, Montreal, Quebec, Canada; Group 2) with nonsurgical embryo transfer 7.5 or 8.0 days later. Cows in Groups 3, 4, and 5 were treated with a CIDR insert (Bioniche Animal Health, Beijing, China), 2 mg estradiol benzoate (EB), and 50 mg progesterone (Sigma-Aldrich, Canada) i.m. on Day 0, PGF on Day 5, CIDR removal on Day 7, and 1 mg EB i.m. 24 h later with nonsurgical transfer of Holstein IVP embryos 8.5 days later, without estrus detection. In addition, cows in Group 3 received no further treatment, whereas cows in Group 4 received 400 IU eCG i.m. (Pregnecol; Bioniche) on Day 5, and cows in Group 5 received eCG on Day 7. Holstein embryos were produced utilizing slaughterhouse ovaries and standard IVF procedures. Expanded blastocysts of quality grade 1 (IETS) were cryopreserved in 10% ethylene glycol and 20% fetal bovine serum using standard procedures. Straws were thawed in a 30�C water bath, and embryos were expelled directly into holding medium and evaluated prior to nonsurgical transfer (NT) ipsilateral to the corpus luteum (CL). Pregnancy was diagnosed ultrasonically 30 d later. Although pregnancy rates, based on numbers of recipients synchronized, numerically favored the administration of eCG on Day 5, there were no significant differences (P = 0.40) among groups (Group 1: 15.4%, n = 52; Group 2: 20.0%, n = 50; Group 3: 19.2%, n = 99; Group 4: 28.1%, n = 96; Group 5: 21.3%, n = 75). In Experiment 2, Chinese Yellow crossbred cattle were synchronized with a CIDR insert plus estradiol and progesterone on Day 0, PGF on Day 5, CIDR removal on Day 7 and estradiol on Day 8, and were randomly assigned to received no further treatment (Group 1; n = 400) or an injection of 400 IU eCG on Day 5 (Group 2; n = 391). Recipients with a detectable CL received a frozen-thawed IVP Holstein embryo by NT 8.5 days after the second injection of estradiol without estrus detection, as in the first experiment. Pregnancy diagnosis was done ultrasonically 30 days later. Although CL size, cow age, and embryo quality, prior to transfer, were recorded, no effects on pregnancy rates were demonstrated (P = 0.30). Pregnancy rates, based on recipients receiving embryos, did not differ (P = 0.5) between groups (Group 1: 21.4%, n = 154; Group 2: 24.5%, n = 290). Overall pregnancy rates (based on the total number of recipients synchronized) were significantly higher (P < 0.001) in Group 2 (eCG; 18.2%) than in Group 1 (no eCG; 8.3%), because of the significantly higher (P < 0.03) percentage of recipients used following treatment with eCG (74.2% vs. 38.5%). Results indicate that the administration of eCG on Day 5 of an 8-d synchronization protocol for FTET of frozen-thawed bovine IVP embryos will improve pregnancy rates in beef recipients, especially those of marginal quality.

Evaluation of the antitumoral effect sunitinib eluting beads in VX2 liver tumour in a rabbit model.

2013 ◽  
Vol 31 (4_suppl) ◽  
pp. 247-247
Author(s):  
Pierre E. Bize ◽  
Olivier Jordan ◽  
Katrin Fuchs ◽  
Olivier Dormond ◽  
Rafael Duran ◽  
...  
Keyword(s):  
Liver Cancer ◽  
Control Group ◽  
Left Liver Lobe ◽  
Antitumoral Effect ◽  
Drug Concentrations ◽  
Group 3 ◽  
Group 2 ◽  
Very High ◽  
Group 1

247 Background: We demonstrated that DC Bead (Biocompatibles UK, Ltd) could be loaded with sunitinib and injected intra-arterially in the rabbit without unexpected toxicity. The purpose of this study is to evaluate the antitumoral effect of sunitinib eluting beads in the VX2 tumor model of liver cancer. Methods: VX2 tumors were implanted in the left liver lobe of New-Zealand white rabbits. Animals were assigned to 3 groups: Group 1 (n=6) received 1.5mg of sunitinib loaded in 0.05ml of 100-300um DC Bead, group 2 (n=5) received 0.05ml of 100-300um DC Bead, group 3 (n=5) received 0.05ml NaCl 0.9% in the left hepatic artery. One animal in each group was sacrificed at 24 hours and the others were followed for survival until day 15. Liver enzymes were measured daily. In group 1, plasmatic sunitinib concentration were measured daily by LC MS/MS tandem mass spectroscopy. At day 15 all living animals were sacrificed. After sacrifice, the livers were harvested for determination of the VEGF receptor tyrosine kinase activity by western blot and histopathological examination. Results: In group 1, no animals died during follow-up. In group 2, 2 animals died during follow-up on day x. In control group 3, 3 animals died during follow up on day x. In group 1 plasmatic sunitinib levels remained under therapeutic concentration throughout the experiment. Very high concentrations of sunitinib were measured in the liver tissue 24 and 15 days after embolization. Inhibition of the phosphorylation of the RTK was demonstrated at 24h and 15 days in groups 1. Sunitinib eluting beads seemed to penetrate in the tumor more effectively and there was more necrosis around the beads than their bland counterparts. Conclusions: Administration of sunitinib eluting beads in VX2 carrying rabbits resulted invery high drug concentrations at the site of embolization with minimal systemic passage. Despite the very high tissular sunitinib concentration we did not observe any additional toxicity with loaded beads. Sunitinib eluting beads inhibit the activation of RTK’s triggered by ischemia and seem to prolong survival of the treated animals. Therefore we consider that local treatment with sunitinib may provide a promising approach for the treatment of liver cancer.

scholarly journals Effect of potassium nitrate plus vitamin C in feed of rabbits on the some biochemical parameters

2017 ◽  
Vol 40 (2) ◽  
pp. 135-139
Author(s):  
Saad Thabit Jassim Alrawi
Keyword(s):  
Vitamin C ◽  
Biochemical Parameters ◽  
Potassium Nitrate ◽  
Control Group ◽  
Daily Group ◽  
Group 4 ◽  
Group 3 ◽  
Group 2 ◽  
C 50 ◽  
Group 1

     This study is conducted at investigating the effect of potassium nitrate and vitamin C in feed of the rabbits on the some biochemical parameters. Twenty eight adult New-Zealand rabbits were divided randomly into four groups (7 rabbits each), they were fed potassium nitrate and vitamin C for 16 weeks as follow: Group 1 (G1) fed potassium nitrate (168 mg/ kg B.W./ daily), group 2 (G2) fed potassium nitrate (168 mg/ kg B.W./ daily) and vitamin C (50 mg/ kg B.W./ daily), group 3 (G3) fed potassium nitrate (168 mg/ kg B.W./ daily)  and vitamin C (100 mg/ kg B.W./ daily) and group 4 (G4) fed basal ration as control group. Blood were collected from heart at zero, eight, twelve and sixteen weeks. The results showed a significant increase (P<0.05) in cholesterol, triglyceride and blood nitrogen urea in the group that had fed potassium nitrate G1 compared with G4, whereas the groups that were fed vitamin C with potassium nitrate showed a mild decrease compared with group potassium nitrate that had been fed potassium nitrate alone (G1). In conclusion, the feeding rabbits with potassium nitrate caused an increase in cholesterol, triglyceride and blood urea concentration in the serum, whereas the vitamin C ameliorates this effect.

367 INFLUENCE OF SUPERESTIMULATION AND HORMONAL DEPRIVATION PROTOCOLS ON IN VITRO PRODUCTION OF NELORE EMBRYOS (BOS TAURUS INDICUS)

2006 ◽  
Vol 18 (2) ◽  
pp. 291 ◽  
Author(s):  
C. M. Barros ◽  
M. M. G. Ferreira ◽  
J. R. Potiens ◽  
B. G. Eberhardt ◽  
D. S. Melo ◽  
...  
Keyword(s):  
Bos Taurus ◽  
Animal Health ◽  
In Vitro Production ◽  
Follicular Maturation ◽  
Group 3 ◽  
Blastocyst Rate ◽  
Group 2 ◽  
Vitro Production ◽  
Group 1

There are indications in the literature that delaying the period between ovarian superestimulation and ovum pickup (OPU) will induce follicles to a condition of initial atresia, which could be beneficial to oocyte development. Blondin et al. (2002 Biol. Reprod. 66, 38–43) superstimulated (FSH) Holstein heifers and delayed OPU for 48 h, i.e. they induced initial atresia in these follicles deprived of FSH (starvation) for 48 h. Additionally, 6 h before OPU, LH was administered to accelerate follicular maturation. This protocol yielded a surprisingly high blastocyst rate (80.4 ± 9.4%). In the present work, Blondin’s protocol was simultaneously compared to other protocols used for OPU and in vitro production of embryos (IVP), in Nelore cattle. Nelore cows (n = 18) were randomly allocated in three groups: Group 1 (just OPU), Group 2 (superestimulation and OPU), and Group 3 (superestimulation associated with FSH deprivation and OPU). Three OPU were performed, and the animals were switched to a different group each time in such a way that at the end of the experiment all cows received the three protocols. At a random stage of the estrous cycle (D2), follicles ≥6 mm were aspirated to induce a new follicular wave 2 days afterward (D0). In Group 1, OPU was performed on D2 and oocytes were processed to IVP. In Group 2, starting on D0, cows were superestimulated (pFSH, Folltropin®, 30 mg administered daily, IM, during 3 consecutive days; Bioniche Animal Health, Belleville, Ontario, Canada), and 6 h after the last FSH dose they received exogenous LH (12.5 mg, Im, Lutropin®, D3; Bioniche Animal Health). OPU was performed 6 h after LH administration, i.e. 12 h after the last dose of FSH. Animals in Group 3 received the same treatment as in Group 2, except that LH was administered 36 h after the last dose of FSH, and OPU occurred 6 h later. Therefore, in this Group, follicles were deprived of FSH during 48 h. Both cleavage and blastocyst rates were similar (P > 0.05, logistic regression) among oocytes from Groups 1, 2, and 3, respectively: 77.4% (144/185) and 42.70% (79/185); 75.54% (105/139) and 31.65% (44/139); 63.52% (101/159) and 33.33% (53/159). However, hatched blastocyst rate was higher (P < 0.01) in Group 1 (30.27%, 56/185) when compared to Group 2 (11.51%, 16/139) or 3 (15.72%, 25/159). It is concluded that, contrary to previous work on European breeds (taurus), ovarian superestimulation associated with deprivation of FSH and OPU (Group 3) do not increase IVP of Nelore embryos (indicus). Additionally, the highest hatched blastocyst rates were observed in oocytes from non superstimulated cows (Group 1).

Integrative assessment of candidate gene polymorphisms distribution by forming a gene modification index in arterial hypertension with and without obesity: a new perspective in cardiology management

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
V Bondar ◽  
K Chernyshova ◽  
H Chernyshova ◽  
S Kolomiiets ◽  
V Klochko ◽  
...  
Keyword(s):  
Arterial Hypertension ◽  
Candidate Gene ◽  
Gene Polymorphisms ◽  
Gene Modification ◽  
Hypertensive Patients ◽  
Integrative Assessment ◽  
Group 3 ◽  
Group 2 ◽  
Very High ◽  
Group 1

Abstract   The concept of evolutionary accumulation of candidate gene polymorphisms in the realization of the hypertensive phenotype becomes promising in understanding of arterial hypertension (AH). A large amount of data about genetic polymorphisms in population have been accumulated and perspective approaches to their integrative assessment are being formulated for practical management. The purpose of the research was to analyze and compare the proportion of modified candidate genes (CG) in the group of hypertensive patients with and without obesity with the group of non-hypertensive patients by calculating the gene modification index (GMI) for the assessment of possible usage of genetic stratification in the management of AH. Methods 106 patients with AH and obesity (age 46.2 [24–72], m/f 79/27), (group 1), 96 hypertensive patients without obesity (age 48.3 [26–75], m/f 72/24), (group 2) and 98 non-hypertensive patients (age 41.6 [26–69], m/f 39/59), (group 3) (ESC/ISH 2018, WHO 1997) were examined. The analysis of polymorphisms of the following CG by PCR was perfomed: ADD1: 1378, AGT: 704, AGT: 521, AGTR1: 1166, AGTR2: 1675, CYP11B2: −344, GNB3: 825, NOS3: −786, NOS3: 894. The GMI which represents the percentage of “pathological” genotypes was formed and calculated by the formula: GMI = (N/13.5) × 100, where N is the sum of points of present GP (“pathological” homozygous was 1,5 points, heterozygous – 1 point, “normal” genotype – 0 points); 13.5 – maximum number of points. The GMI from 0 to 20% was considered as low genetic risk (GR), from 21 to 40% – moderate GR, from 41 to 70% – high GR, from 71 to 100% – very high GR. Results In patients with AH and obesity, a low GR was in 4 (3.8%), in the group of hypertensive patients without obesity – 13 (13.5%), in normotensive patients – in 81 (82.7%) (p1–3 = 0.0001, p2–3 = 0.0001, p1–2 = 0.02). Moderate GR was observed in 21 (19.8%) patients of the 1st group, in 25 (26%) patients of the 2nd group and in 12 (12.2%) patients of the 3rd group (p1–3 = 0.07, p2–3 = 0.01, p1–2 = 0.02). 54 (50.9%) patients of group 1, 41 (42.7%) patients of group 2 and 5 (5.1%) of patients of group 3 had a high GR (p1–3 = 0.0001, p2–3 = 0.0001, p1–2 = 0.08); a very high GR was in 27 (25.5%) patients of the 1st group, in 17 (17.8%) of the 2nd group and was absent in the patients of the 3rd group (p1–3 = 0.0001, p2–3 = 0.0001, p1–2 = 0.02). The average GMI in group 1 was 66.2% [CI 95%, 20–78], in group 2 – 56.4% [CI 95%, 18–72], in group 3 – 22% [CI 95% 5–41], (p1–3 = 0.0001, p2–3 = 0.0001, p1–2 = 0.04). Conclusions It was revealed a strong significant predominance of the proportion of modified CG in hypertensive patients with and without obesity compared with non-hypertensive patients. There was a moderate significant difference between hypertensive patients, depending on the presence of obesity. Evaluation of GMI is a perspective direction in the diagnosis and prevention of AH and can be used in practical management. Funding Acknowledgement Type of funding source: None

Sign in / Sign up

Export Citation Format

Share Document